Download | < Back |
16 Jun 2014 | |
With reference to earlier announcement dated May 30, 2014 regarding allotted 35,00,000 equity shares of Rs. 110 each (including a premium of Rs. 108 per share) and 71,00,000 convertible warrants at a price of Rs. 110 per warrant and each warrant will be converted into one equity share to M/s. Sequent Scientific Ltd, Mumbai, on preferential basis. Shasun Pharmaceuticals Ltd has now submitted to BSE about the Shareholding Pattern for the ended May 30, 2014. | |
View all announcements for SHASUN PHARMACEUTICALS LTD. | Source: BSE India |